Enjoy complimentary customisation on priority with our Enterprise License!
Market research analysts at Technavio predict that the global hospital-acquired infection control market will grow steadily at a CAGR of around 5% by 2021. The adoption of data analytics to improve healthcare facilities is identified as one of the primary growth factors for this market. Data analytics refers to the collection of tools and techniques that are used to generate insights and take actions based on real-time data.
Over the years, the healthcare systems have been collecting data through electronic medical records (EMRs) and electronic health records (EHRs). When this data is analyzed using numerous data analytics techniques, it helps reach valuable conclusions and deductions that can be used to improve healthcare settings and even reduce the prevalence of hospital-acquired infection (HAIs). Several information technology companies are employing various algorithms to arrive at inferences that could help improve hospital-acquired infection control. Additionally, government organizations also use data analytics to improve their measures to tackle hospital-acquired infections.
In terms of geographic regions, the Americas will be the major revenue contributor to the hospital-acquired infection control market throughout the forecast period. The increase in hospital-acquired infection research and the launch of new products drive the market’s growth in this region. Moreover, the rise in government initiatives to combat the rising occurrences of hospital-acquired infections will also boost the growth of the hospital-acquired infection control market in this region.
The hospital-acquired infection control market is quite competitive and consists of leading pharmaceutical companies who account for most of the market shares. Companies with limited experience are developing innovative solutions to control hospital-acquired infections. Investments in the manufacturing to expand production facilities and considerable efforts to develop advanced drugs that can cure hospital-acquired infections are the key strategies employed by the market players. To expand the customer base, some key companies are also focusing on launching products with equitable prices that can be profitable for the company and affordable for the patients.
During 2016, the CAUTIs segment accounted for the major shares of the hospital-acquired infection control market. Factors such as the increase in the number of hospital admissions due to urinary tract infections (UTIs) and the improper maintenance of healthcare facilities, will contribute to the growth of this industry segment in the coming years.
As per this market research report, hospitals and ICUs held the maximum market share of the hospital-acquired infection control market during 2016. The prevalence of hospital-acquired infections is high in hospitals and ICUs as they lack adequate maintenance due to the high volume of patients and limited budgets. Moreover, the staff shortage in hospitals and ICUs also increases the prevalence of HAIs as patients do not get the required attention. These factors will drive the growth in demand for hospital-acquired infections control products from hospitals and ICUs during the forecast period.
Want a bigger picture? Try a FREE sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Segmentation by infection type
PART 07: Segmentation by end-user
PART 08: Segmentation by geography
PART 09: Decision framework
PART 10: Drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
PART 14: Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.